Hadassah

Alzheimer’s Further Illuminated at Hadassah with New Exclusive Imaging Agent

Tuesday, Aug 13 2019

The Hadassah Medical Organization, through its subsidiary SRY, has contracted to be the sole Israeli agent for General Electric to produce Vizamyl, the company’s new radioactive imaging agent to detect, at an early stage, amyloid plaque, which has been linked to the development of Alzheimer’s disease.

“Finding that a patient does not have plaque allows neurologists to rule out a diagnosis of Alzheimer’s,” relates Prof. Eyal Mishani, head of Research and Development at Hadassah and its Cyclotron Radiochemistry Unit within the Nuclear Medicine Institute.   

“The presence of plaque in the brain,” he explains, “means that you are at risk for Alzheimer’s. In that case, you can investigate activities that might mitigate the process or, if the process is unstoppable, make more informed life plans.”

Finding plaque isn’t an absolute diagnosis of Alzheimer’s. Although moderate density and frequency of plaque deposits have been shown to be present in patients with Alzheimer’s disease, according to GE, this plaque “may also be present in patients with other types of neurologic conditions, as well as in older people with normal cognition.”

Vizamyl is used in conjunction with Positron Emission Tomography (PET) to reveal the density of plaque. Some individuals being tested may have already experienced cognitive decline. Others with a family history of Alzheimer’s may wish to identify their status. Although Vizamyl has already been successfully tested in clinical trials for safety and effectively highlighting plaque, the test isn’t yet covered by Israeli health insurance. It costs about 7,000 shekels, out of pocket.  

The new imaging agent will also enable physicians to compare a patient’s plaque density at the beginning versus the end of a treatment regimen, providing data as to the treatment’s success during clinical trials.

Learn more about the Hadassah Medical Organization.

Related Stories

alt_text

Tuesday, Aug 4 2020

Kidney Donation Keeps on Giving: A Hadassah Story

It is said that one good turn leads to another. Two years ago, Hadassah clinical psychologist Benny Kashany altruistically donated a kidney to a total stranger.

READ MORE ›
alt_text

Monday, Aug 3 2020

Hadassah Physician Turns to SodaStream to Ease COVID-19 Patients’ Breathing

How’s this for thinking outside of the box? Seeking a better device than the invasive ventilator to ease COVID-19 patients’ breathing difficulties...

READ MORE ›
alt_text

Monday, Aug 3 2020

Hadassah Treats 9-Year-Old With Mysterious Bullet Lodged in His Brain

Last Friday, on the Muslim holiday of Eid al-Adha, in the Jerusalem neighborhood of Ras al-Amud, a stray bullet hit a 9-year-old boy in the head.

READ MORE ›
alt_text

Friday, Jul 31 2020

Six Hadassah Researchers Receive Major Grants From Israel Science Foundation

Researchers at the Hadassah Medical Organization (HMO) received six of the eight coveted awards granted this year by the Israel Science Foundation...

READ MORE ›

Donation Questions

donorservices@hadassah.org

(800) 928-0685

Membership Questions

membership@hadassah.org

(800) 664-5646

Israel Travel

israeltravel@hadassah.org

(800) 237-1517

Contact Us

40 Wall Street

New York, NY 10005

support@hadassah.org

More ›

Show More